[
  {
    "ts": "2025-12-17T22:08:00+00:00",
    "headline": "Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress",
    "summary": "We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Pfizer Inc tops our list for being one of the most undervalued pharmaceutical stocks. On Friday, December 12, 2025, The Fly reported that Morgan Stanley maintained its Hold (Equal‑Weight) rating on PFE., while lowering the price target to $28 from […]",
    "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-rating-steady-220800196.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "abaa876e-c6c1-35c6-8e7d-f6ec31a2cd5b",
      "content": {
        "id": "abaa876e-c6c1-35c6-8e7d-f6ec31a2cd5b",
        "contentType": "STORY",
        "title": "Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress",
        "description": "",
        "summary": "We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Pfizer Inc tops our list for being one of the most undervalued pharmaceutical stocks. On Friday, December 12, 2025, The Fly reported that Morgan Stanley maintained its Hold (Equal‑Weight) rating on PFE., while lowering the price target to $28 from […]",
        "pubDate": "2025-12-17T22:08:00Z",
        "displayTime": "2025-12-17T22:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e07100855b9769c67c145e877d715493",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JdsUG2H00H23uAd7a0c6qw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e07100855b9769c67c145e877d715493.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QqxTp0yGkKMLrei39SQnQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e07100855b9769c67c145e877d715493.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-rating-steady-220800196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-rating-steady-220800196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T17:07:00+00:00",
    "headline": "If I Could Only Buy and Hold a Single Stock, This Would Be It",
    "summary": "Pfizer's shares look attractive to investors willing to show patience.",
    "url": "https://www.fool.com/investing/2025/12/17/if-i-could-only-buy-and-hold-a-single-stock-this/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e765e761-b1cc-37b1-bdd7-30ebd91808f8",
      "content": {
        "id": "e765e761-b1cc-37b1-bdd7-30ebd91808f8",
        "contentType": "STORY",
        "title": "If I Could Only Buy and Hold a Single Stock, This Would Be It",
        "description": "",
        "summary": "Pfizer's shares look attractive to investors willing to show patience.",
        "pubDate": "2025-12-17T17:07:00Z",
        "displayTime": "2025-12-17T17:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/236449c144cee979e73a19ccc9a37237",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "A young child receiving a shot.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XF2BVq.i0mJ3sVuDGgoT0g--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/236449c144cee979e73a19ccc9a37237.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TyTqHrJpY1eSZ4d08Q7PLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/236449c144cee979e73a19ccc9a37237.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/17/if-i-could-only-buy-and-hold-a-single-stock-this/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/could-only-buy-hold-single-170700119.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T16:26:00+00:00",
    "headline": "CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy?",
    "summary": "CorMedix's DefenCath sales and Melinta deal raise growth stakes while Puma Biotechnology's Nerlynx-led breast cancer franchise aids growth.",
    "url": "https://finance.yahoo.com/news/crmd-vs-pbyi-small-cap-162600817.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "05b7e7e9-4469-3459-b28d-3e6622f602fe",
      "content": {
        "id": "05b7e7e9-4469-3459-b28d-3e6622f602fe",
        "contentType": "STORY",
        "title": "CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy?",
        "description": "",
        "summary": "CorMedix's DefenCath sales and Melinta deal raise growth stakes while Puma Biotechnology's Nerlynx-led breast cancer franchise aids growth.",
        "pubDate": "2025-12-17T16:26:00Z",
        "displayTime": "2025-12-17T16:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H9Y3er.afSc3GhCdnEPJDg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A8kFZZ9VHNy5RXuATQIZdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crmd-vs-pbyi-small-cap-162600817.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crmd-vs-pbyi-small-cap-162600817.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRMD"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "PBYI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T14:59:00+00:00",
    "headline": "Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?",
    "summary": "PFE's soft 2026 outlook spooks investors, with revenue and EPS guidance trailing expectations as COVID-19 demand fades and patent losses mount.",
    "url": "https://finance.yahoo.com/news/pfizer-issues-soft-2026-view-145900252.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "448c23a6-11ee-3e4a-a8aa-fe2d7d799bf0",
      "content": {
        "id": "448c23a6-11ee-3e4a-a8aa-fe2d7d799bf0",
        "contentType": "STORY",
        "title": "Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future?",
        "description": "",
        "summary": "PFE's soft 2026 outlook spooks investors, with revenue and EPS guidance trailing expectations as COVID-19 demand fades and patent losses mount.",
        "pubDate": "2025-12-17T14:59:00Z",
        "displayTime": "2025-12-17T14:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tTGp.ukDgQsfJ2wtQbOlpQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EgPFAUyZvvJjYrTV0pc.LQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-issues-soft-2026-view-145900252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-issues-soft-2026-view-145900252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T14:51:00+00:00",
    "headline": "Company News for Dec 17, 2025",
    "summary": "Companies in The News Are: PFE,KHC,F,PYPL",
    "url": "https://finance.yahoo.com/news/company-news-dec-17-2025-145100121.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9e93826d-5580-3ee6-9a48-ea62ecedc096",
      "content": {
        "id": "9e93826d-5580-3ee6-9a48-ea62ecedc096",
        "contentType": "STORY",
        "title": "Company News for Dec 17, 2025",
        "description": "",
        "summary": "Companies in The News Are: PFE,KHC,F,PYPL",
        "pubDate": "2025-12-17T14:51:00Z",
        "displayTime": "2025-12-17T14:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tTGp.ukDgQsfJ2wtQbOlpQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EgPFAUyZvvJjYrTV0pc.LQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44f6a0d2318749b70fea99c7e1845c48.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/company-news-dec-17-2025-145100121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/company-news-dec-17-2025-145100121.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "K"
            },
            {
              "symbol": "F"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T13:35:00+00:00",
    "headline": "The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now",
    "summary": "It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.",
    "url": "https://www.fool.com/investing/2025/12/17/the-ultimate-high-yield-drug-stock-to-buy-with-100/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "9233b106-7d85-38f7-9290-ac90a95f74e2",
      "content": {
        "id": "9233b106-7d85-38f7-9290-ac90a95f74e2",
        "contentType": "STORY",
        "title": "The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now",
        "description": "",
        "summary": "It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.",
        "pubDate": "2025-12-17T13:35:00Z",
        "displayTime": "2025-12-17T13:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/446a901974576a604560f17afbe850f8",
          "originalWidth": 1199,
          "originalHeight": 800,
          "caption": "A person with their hands out as if weighing their options.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CoH78cbA5pc1tlB5T_Jwgg--~B/aD04MDA7dz0xMTk5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/446a901974576a604560f17afbe850f8.cf.webp",
              "width": 1199,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MAvXWqKQx2egCEN_LBYLKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/446a901974576a604560f17afbe850f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/17/the-ultimate-high-yield-drug-stock-to-buy-with-100/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ultimate-high-yield-drug-stock-133500875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T12:28:33+00:00",
    "headline": "Stocks Gain Pre-Bell as Traders Parse Latest Employment Data",
    "summary": "The main US stock measures were tracking in the green in Wednesday's premarket activity as traders d",
    "url": "https://finance.yahoo.com/news/stocks-gain-pre-bell-traders-122833951.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "f6b0b19a-fcf5-3eba-8836-d0c624d953cc",
      "content": {
        "id": "f6b0b19a-fcf5-3eba-8836-d0c624d953cc",
        "contentType": "STORY",
        "title": "Stocks Gain Pre-Bell as Traders Parse Latest Employment Data",
        "description": "",
        "summary": "The main US stock measures were tracking in the green in Wednesday's premarket activity as traders d",
        "pubDate": "2025-12-17T12:28:33Z",
        "displayTime": "2025-12-17T12:28:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "stock trading floor NYSE market wall street  - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IeAizqJZBy9vwDXxekAvFA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OyOVBGCbqGk3V7zjfLwvvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/ebc5b64c4dc98d6f607464cb4d50ba3d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-gain-pre-bell-traders-122833951.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-gain-pre-bell-traders-122833951.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T11:45:00+00:00",
    "headline": "PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility",
    "summary": "Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, \"Astellas\") and Pfizer Inc. (NYSE: PFE) today announced positive topline results from an interim analysis of the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for PADCEV™ (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda® (pembrolizumab), a PD-1 inhibitor. This pivotal study is evaluating the combination as neoadjuvant and adjuvant treatment (before and after surgery) vers",
    "url": "https://finance.yahoo.com/news/padcev-plus-keytruda-significantly-improves-114500444.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "6be71c0d-1eb8-31d0-b504-2a2710e29b6a",
      "content": {
        "id": "6be71c0d-1eb8-31d0-b504-2a2710e29b6a",
        "contentType": "STORY",
        "title": "PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility",
        "description": "",
        "summary": "Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, \"Astellas\") and Pfizer Inc. (NYSE: PFE) today announced positive topline results from an interim analysis of the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for PADCEV™ (enfortumab vedotin), a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda® (pembrolizumab), a PD-1 inhibitor. This pivotal study is evaluating the combination as neoadjuvant and adjuvant treatment (before and after surgery) vers",
        "pubDate": "2025-12-17T11:45:00Z",
        "displayTime": "2025-12-17T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/2ea847d4f0afcbab05cc0666e5cfd53b",
          "originalWidth": 400,
          "originalHeight": 110,
          "caption": "Astellas stands on the forefront of healthcare change to turn innovative science into value for patients.(PRNewsFoto/Astellas Pharma Inc.) (PRNewsfoto/Astellas Pharma Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m8ZpamkfFQbGFV5I_uv29A--~B/aD0xMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2ea847d4f0afcbab05cc0666e5cfd53b.cf.webp",
              "width": 400,
              "height": 110,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lVr.91JQj9lrDNRXh8gT2A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2ea847d4f0afcbab05cc0666e5cfd53b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/padcev-plus-keytruda-significantly-improves-114500444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/padcev-plus-keytruda-significantly-improves-114500444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALPMF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ALPMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-17T07:30:00+00:00",
    "headline": "Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic",
    "summary": "COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the Company’s Articles of Association, the Board has convened and has appointed Ms. Heidi Hunter as new Vice Chair. Ms. Hunter has been a member of the board since 2023. She has over 25 years of industry experience, working across the pharmaceutical value chain, from clinical and comm",
    "url": "https://finance.yahoo.com/news/heidi-hunter-appointed-vice-chair-073000713.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "561e1fdb-2037-396a-9c84-57d4fe9150fb",
      "content": {
        "id": "561e1fdb-2037-396a-9c84-57d4fe9150fb",
        "contentType": "STORY",
        "title": "Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic",
        "description": "",
        "summary": "COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the Company’s Articles of Association, the Board has convened and has appointed Ms. Heidi Hunter as new Vice Chair. Ms. Hunter has been a member of the board since 2023. She has over 25 years of industry experience, working across the pharmaceutical value chain, from clinical and comm",
        "pubDate": "2025-12-17T07:30:00Z",
        "displayTime": "2025-12-17T07:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/75d59939e77fd98fb5d7db1adb77442c",
          "originalWidth": 224,
          "originalHeight": 118,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7fEZ3KV_w.i9s_XQDdUI_A--~B/aD0xMTg7dz0yMjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/75d59939e77fd98fb5d7db1adb77442c.cf.webp",
              "width": 224,
              "height": 118,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DRlD9k9LsuGtvt8VhsW7Mg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/75d59939e77fd98fb5d7db1adb77442c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heidi-hunter-appointed-vice-chair-073000713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heidi-hunter-appointed-vice-chair-073000713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BVNKF"
            },
            {
              "symbol": "BVNRY"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]